ArticleJournal of neural transmission (Vienna, Austria : 1996)2026
The impact of depressive symptoms on 5-year all-cause mortality in patients with parkinson's disease treated with and without deep brain stimulation.
Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This retrospective single-center study evaluated the impact of depressive symptoms on survival in patients with Parkinson's disease (PD) treated with deep brain stimulation (DBS) or best medical treatment (BMT). A total of 421 patients (337 BMT, 84 DBS) from the Medical University of Vienna were included, with data collected between 1999 and 2024. Depressive symptoms were assessed using the Geriatric Depression Scale (GDS), and cognitive performance was evaluated using subtests of the Neuropsychological Test Battery Vienna (NTBV). A Cox proportional hazards model was applied to examine the predictive value of depressive symptoms and additional covariates, including age, gender, education, and cognitive function. Increasing age and male sex were significant risk factors for increased mortality. While depressive symptoms showed an initial association with survival, their predictive strength diminished when cognitive and demographic factors were included. Cognitive performance, particularly attention and executive functioning, assessed by NTBV-15, showed significant protective effects. Five-year survival was 73.4% in the BMT group and 88.2% in the DBS group (p < .05), though therapy type itself was not a significant predictor in the regression model. These findings suggest that depressive symptoms may contribute to mortality in PD patients but appear to be outweighed by cognitive and demographic variables. Cognitive assessment may offer additional prognostic value in long-term outcome prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.